Stockreport

Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults

BAVARIAN NORDIC R/I S/ADR  (BVNRY) 
NASDAQ:AMEX Investor Relations: bavarian-nordic.com/investor.aspx
PDF First FDA approved non-replicating smallpox vaccineOnly FDA approved vaccine for prevention of monkeypoxCompany granted Priority Review VoucherConference call and webcas [Read more]